Clinical Trials Directory

Trials / Sponsors / Lykos Therapeutics

Lykos Therapeutics

Industry · 29 registered clinical trials1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingMDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function
Pharmacokinetics, Hepatic Impairment
Phase 12026-03-29
WithdrawnA Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders
Anorexia Nervosa Restricting Type, Binge-Eating Disorder
Phase 22026-02-01
WithdrawnPsychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)
Psychological Effects of Study Drug
Phase 12024-12-01
WithdrawnStudy of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans
PTSD
Phase 22023-09-01
WithdrawnStudy of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
Posttraumatic Stress Disorder
Phase 22022-08-01
CompletedFood Effects on Bioavailability of MDMA in Healthy Volunteers
Pharmacokinetics
Phase 12022-07-28
TerminatedStudy Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD
PTSD
Phase 22021-11-08
CompletedA Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
PTSD
Phase 32021-03-08
CompletedLong-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD
PTSD
2021-03-01
CompletedA Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)
Posttraumatic Stress Disorder
Phase 32020-09-02
CompletedA Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)
Posttraumatic Stress Disorder
Phase 32018-11-21
CompletedStudy of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)
Posttraumatic Stress Disorder
Phase 22018-03-13
CompletedOpen Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
PTSD
Phase 22017-11-16
CompletedEvaluation of MDMA on Startle Response
Startle Response
Phase 12017-03-14
CompletedMDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD
Posttraumatic Stress Disorder
Phase 1 / Phase 22016-07-03
CompletedCorrelates of Anxiety Associated With a Life-threatening Illness
Anxiety
2015-11-07
CompletedMDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness
Anxiety
Phase 22015-05-14
TerminatedRandomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD
Posttraumatic Stress Disorder
Phase 22014-10-14
CompletedPhase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults
Social Anxiety in Autistic Adults
Phase 22014-04-11
CompletedExploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD
Posttraumatic Stress Disorder
2014-01-01
CompletedDose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
Posttraumatic Stress Disorder
Phase 22013-05-13
CompletedRandomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSD
Posttraumatic Stress Disorder (PTSD)
Phase 22013-01-17
CompletedPsychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers
Psychological Effects of Study Drug
Phase 12011-04-09
CompletedAdditional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
Posttraumatic Stress Disorder
Phase 22010-12-15
CompletedStudy Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder
Posttraumatic Stress Disorder
Phase 22010-11-10
TerminatedRandomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel
Posttraumatic Stress Disorder
Phase 22007-05-27
CompletedStudy of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
Posttraumatic Stress Disorder
Phase 22006-09-13
CompletedMDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder
Posttraumatic Stress Disorder
Phase 22004-03-12
No Longer AvailableA Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTS
Post Traumatic Stress Disorder